ライフサイエンスコーパス: each group

1 Two eyes underwent redislocation (1 in each group).

2 We included 40 patients (20 in each group).

3 r vaccine or placebo (15,210 participants in each group).

4 race were divided into two groups (n = 13 in each group).

5 wards also (2 female-only and 1 male-only in each group).

6 lled and randomly assigned 660 women (330 in each group).

7 onary toxicities was similar (one patient in each group).

8 included 282/300 (94%) children (n = 141 in each group).

9 and VRC 320 enrolled 45 participants (15 in each group).

10 t least one dose of study medication (181 in each group).

11 notification or study procedures occurred in each group).

12 ted 6 months study follow-up (15 patients in each group).

13 in the intention-to-treat population (64 in each group).

14 one or two doses of monovalent OPV2 (n=50 in each group).

15 c data were obtained from 66 patients (33 in each group).

16 ere all frozen shoulders (in two patients in each group).

17 tory tract infections (five [5%] patients in each group).

18 cebo group), and myalgia (one [2%] person in each group).

19 ose with PVR-A, PVR-B, and PVR-C (n = 10 for each group).

20 ht or 50-lux dim red placebo light (N=23 for each group).

21 low or medium dose insulin infusion (n = 10 each group).

22 and 98 with placebo) and 200 deaths (100 in each group).

23 PE, GDM, or uncomplicated pregnancy (n = 10 each group).

24 ctively), and headache (17 [15%] patients in each group).

25 A total of 54 children were recruited (27 in each group).

26 a number of the forebrain regions (n = 5 in each group).

27 total of 1044 patients were matched (348 in each group).

28 trol group that received PCI only (n = 50 in each group).

29 4 were included in the final analysis (62 in each group).

30 were randomly assigned to treatment (100 to each group).

31 s increased in both ApoE groups (P = 0.03 in each groups).

32 omes and key risk and protective factors for each group.

33 There was 1 unplanned hysterectomy in each group.

34 ge of 56 years; 78 patients were assigned to each group.

35 itted accurate automated classification into each group.

36 e end points were compared between donors in each group.

37 We included five animals into each group.

38 e participants at the previous lower dose in each group.

39 related quality of life were not affected in each group.

40 -adjusted mortality rates were calculated in each group.

41 nderwent randomization, with 216 assigned to each group.

42 Baseline HIV prevalence was 21% or 22% in each group.

43 Forty participants completed the study in each group.

44 lities and scope of work to be undertaken by each group.

45 d; one serious adverse event was reported in each group.

46 morrhage occurred in 4.5% of the patients in each group.

47 proximately 90 ms prior to movement onset in each group.

48 y experts (N = 12) with representatives from each group.

49 matching analysis extracted 63 patients from each group.

50 Eight serious adverse events occurred in each group.

51 f UTIs caused by E coli vaccine serotypes in each group.

52 kalaemia occurred in eight (14%) patients in each group.

53 33 participants were randomly assigned to each group.

54 lycemia events occurred in 2 participants in each group.

55 ) were enrolled, and 112 were randomized for each group.

56 and only 1 case of femoral shaft fracture in each group.

57 remaining free of encephalopathy was 65% for each group.

58 We enrolled 680 patients in each group.

59 o was compared among different visits within each group.

60 by contrast sensitivity and glare tests for each group.

61 tients revealed improvement in 4 patients in each group.

62 and equal probabilities of being assigned to each group.

63 une 16 and Oct 10, 2015, and analysed 835 in each group.

64 red pathways of cytotoxic response shared by each group.

65 endent duplication events in the ancestor of each group.

66 identified in at least 80% of individuals in each group.

67 eaths occurred, but 1 graft loss occurred in each group.

68 s of hippocampal volume assessed with MRI in each group.

69 10) viral particles--with 20 participants in each group.

70 adverse events occurred in four patients in each group.

71 Forty-eight patients were enrolled, 24 in each group.

72 pigs were excluded leaving n equals to 7 for each group.

73 osure, with the same total dose delivered to each group.

74 atients were randomized to MRI navigation in each group.

75 ore on the numerical rating scale was 8.4 in each group.

76 f the 44 patients completed the study, 19 in each group.

77 olled, of whom 133 were randomly assigned to each group.

78 r in TW, with little change over time within each group.

79 raints imposed during the early evolution of each group.

80 hose patients, 128 were enrolled, with 64 in each group.

81 erent trophic groups and several taxa within each group.

82 Ninety-two patients were enrolled in each group.

83 ups and a weighted list of feature genes for each group.

84 low-up to 24 weeks, including four deaths in each group.

85 nslation factor to shift each dataset within each group.

86 d by global mutagenesis are conserved within each group.

87 ticipate, and four were randomly assigned to each group.

88 suvastatin, and one serious adverse event in each group.

89 d S-glutathionylated serpins were similar in each group.

90 m liver failure had received isoniazid [1 in each group]).

91 ences between groups in fever (2 patients in each group: 1.78% vs 1.76%; P = 1.00) or other adverse e

92 sions of patients who did not undergo PCI in each group (337 in the PCI and thrombectomy group and 33

93 fant deaths at age 0-6 months was similar in each group (50 in the placebo group and 61 in the vaccin

94 ltegravir, 59 efavirenz) and infants (25% in each group; 50 raltegravir, 48 efavirenz), with no treat

95 Of the infants assigned to each group, 507 in the measles-rubella plus LJEV group a

96 se events were similar among mothers (30% in each group; 61 raltegravir, 59 efavirenz) and infants (2

97 determinate, 1 was found to be metastatic in each group (8% and 6%, respectively).

98 ys was low (4%) and occurred in 1 patient in each group (95% CI, 0.06 to 16.93; P > .99).

99 R assay with primers and probes specific for each group (A to G) and subgroup E4 (Octaplex) to one wi

100 mean reduction in Hb at day 7 was similar in each group, a difference in the ACT + PQ versus the ACT

101 e to refractory intracranial hypertension in each group (abusive head trauma, 66.7% vs nonabusive hea

102 g a propensity score matching 95 patients of each group according to baseline features, similar resul

103 In each group, acute limb ischemia occurred in 1.7% of the

104 ORs) with 95% confidence intervals (CIs) for each group, adjusted for age and sex.

105 d were randomized to G-CSF or placebo (14 in each group after exclusions).

106 Mean grey values were calculated for each group after measuring the grey scale LMTK2 signal i

107 There were 5,445 patients in each group after propensity score matching.

108 In aim 1, 136 patients remained in each group after PS matching.

109 In aim 2, 77 patients remained in each group after PS matching.

110 igher than that before the DMEK procedure in each group (all P < .05).

111 Three serious adverse events occurred in each group, all considered unrelated to treatment and re

112 Five patients (12%) resumed dialysis in each group and a total of 17 patients died (eight in the

113 ure and hyperexcitable pattern predictors in each group and determine seizure risk with thalamic invo

114 825 women were assigned to each group and included in analyses.

115 or early termination visit was determined in each group and statistically compared using analysis of

116 t pair virtually monopolizes reproduction in each group and subordinate group members help to rear of

117 for the largest share of the total costs in each group and was also lower in the intervention group

118 ue procedure for samples of large size(30 in each group) and medium size (15 in each group) for eithe

119 The overall incidence (34 [83%] of 41 in each group) and severity of adverse events (two [5%] of

120 were nasopharyngitis (eight [8%] patients in each group) and upper respiratory tract infections (five

121 the GDM and non-diabetic subjects (n = 6 for each group), and the platelets and trophoblasts were iso

122 VRC 319 enrolled 80 participants (20 in each group), and VRC 320 enrolled 45 participants (15 in

123 estrictions to the number of participants in each group, and 30 (63%) volunteers were sequentially al

124 ere within the normal range, were similar in each group, and did not change over time.

125 elf establishing the baseline performance of each group, and in the other condition, it was performed

126 ur cases of postpolypectomy bleeding [two in each group], and one case of anxiety and hyperventilatio

127 Results for each group are described.

128 rategy, the consensus RNA-binding pockets in each group are identified.

129 the types of goods and services consumed by each group are less important.

130 Representative bioelectronic systems for each group are summarized based on various stages of a c

131 as differed for the proportion of neurons in each group, as the fraction of chosen value cells was si

132 e appropriate as clinical trial outcomes for each group, as well as those that might be appropriate f

133 Infarct size and LV mass decreased >/=30% in each group at 6 months and declined gradually to 2 years

134 yses were performed in nerves harvested from each group at different survival times.

135 ignificant differentially expressed genes in each group at each timepoint.

136 ed threshold (among the first 38 patients in each group, at least 24 patients were alive and disease

137 The prevalence of PCV was determined in each group based on ICGA.

138 e the region-specific divergence in CNVR for each group based on unbiased estimates of pairwise V ST

139 nvertebrates for 24 weeks, switching half of each group between treatments after 12 weeks.

140 There were two patient deaths (one in each group), but these were not deemed to be related to

141 Three new cases of allergy developed in each group, but after 12 months of avoidance there was n

142 symptomatic patients (nine of 17 patients in each group) by reader 2, without significant differences

143 intention-to-treat population (178 [77%] in each group completed 26 weeks of treatment).

144 82 participants were enrolled, and 41 in each group comprised the ITT population; 33 participants

145 In week two, half of each group (Con + Ir and DSS + Ir) received injections o

146 Each group contained primary and recurrent samples, and

147 ats were divided into three groups (n = 7 in each group): control; periodontitis (periodontitis induc

148 After PADN procedure, 2 patients (1 in each group) developed groin hematoma that resolved witho

149 About 25% of the patients in each group deviated from the assigned therapy, mainly be

150 For each group, diaphragm force production, posttranslationa

151 Three patients in each group did not complete any PRO instruments at any t

152 Of these patients, one in each group did not complete any PRO instruments before w

153 One participant from each group did not receive plasma.

154 Six patients from each group did not receive treatment.

155 One patient (<0.1%) in each group died.

156 Four patients (2 in each group) died within the first 30 postoperative days.

157 Two participants, one in each group, died during treatment; neither death was con

158 fat-, and western-diet for 8 weeks and then each group divided in two smoker and nonsmoker subgroups

159 HCs and the postnatal changes that occur in each group during maturation could lead to therapies for

160 One atypical femoral fracture occurred in each group during the extension.

161 There were seven deaths in each group, either during study treatment or within 30 d

162 Among the 1054 participants (527 in each group), end-point data were available for 1015 (96.

163 layed HIV assisted partner services (nine in each group), enrolling 1305 625 (48%) in the immediate g

164 ever, these rhythms were not synchronous, as each group exhibited its own phase of activation.

165 space indicates that the phenotypic range of each group extends well beyond its overall genetic backg

166 and normal control (subjects number = 564 in each group) following abdominal US study and matching ag

167 ed to identify 147 well-balanced patients in each group for overall survival comparison.

168 nd random forest to evaluate the accuracy of each group for predicting preterm birth cases.

169 Serum level of FGF21 decreased by 50% in each group (for AP diet P < .0002; for PP diet P < .0002

170 ize(30 in each group) and medium size (15 in each group) for either independent, somewhat correlated,

171 ough increased perfusion was observed within each group from baseline to 6 months (P<0.001).

172 89 matched controls (64 males, 25 females in each group) from the Human Connectome Project.

173 Probabilities of assignment to each group (GERD, non-GERD, or EoE) were estimated using

174 The primary efficacy outcome was similar in each group (good outcome in alteplase group 48% vs salin

175 e or in the control group; three patients in each group had >/=50% reduction in level of proteinuria.

176 Each group had 118-239 maternal blood specimens and 100-

177 nd phase, similar proportions of patients in each group had AEs (42% in the placebo group and 32% in

178 atched for age, education, and sex to ensure each group had at least 60 participants with imaging dat

179 At 8 weeks, each group had clinically meaningful reductions in CST r

180 Four patients (6%) in each group had reconstructive failure with implant loss,

181 d 12-month follow-up, similar proportions in each group had remission of depression (425 [76%] in the

182 single vs multiple cells ionizations within each group have also consistently showed this same behav

183 Ninety patients in each group (high-flow nasal oxygen or standard oxygen) w

184 ted significant changes from baseline within each group in microperimetry PRT and AT and in the inter

185 ned to the respective flight capabilities of each group in relation to the wind currents they travel

186 ion outside PFC and 10 healthy participants (each group included both females and males).

187 8-10 weeks old were grouped (six animals in each group) into sham surgery (sham group), left anterio

188 gistic regression analysis was conducted for each group.Iron deficiency, malaria, breastfeeding, stun

189 Each group is characterized by a particular chemical rea

190 A final template of themes from each group is presented together with differences outlin

191 For each group, linear indices were calculated, taking into

192 d in the overall fat measurements and within each group (low, medium and high fat milk) using the thr

193 For each group (<40 y and >/=40 y), 107 patients were includ

194 n, influenza B/Brisbane/60/2008, were low in each group, making comparisons uninterpretable.

195 e subsequently isolated, and preparations in each group matched for SCS or total preservation time we

196 The specific pattern of deficits observed in each group may help guide development of treatments desi

197 ases in which a subset of individuals within each group may initiate fights in which all group member

198 42.1 [10.7] vs 43.0 [10.5] years; 30 men in each group; mean [SD] body mass index, 33.7 [5.1] vs 33.

199 With 34 patients in each group, no notable differences were identified with

200 of 400 pg/mL (representing most patients in each group), NT-proBNP had similar predictive value for

201 ding outcome, P value, number of patients in each group, number of events in each group, number of pa

202 patients in each group, number of events in each group, number of patients lost to follow-up, and tr

203 For each group of clinically related disorders, physicians f

204 Mutation propensities within each group of domains were then averaged to select resid

205 For each group of donors (32 healthy controls, 43 allergic r

206 nd etomoxir as examples, we demonstrate that each group of dose-response patterns identified by TOXcm

207 Yet within each group of fate-changing transcription factors, a sub

208 When each group of measurements is distributed in space, the

209 us group discussions including neighbours of each group of prototype housing.

210 Each group of sensory neurons suppresses distinct integr

211 There was one death in each group of the extension study and both were secondar

212 two sets of conditions are chemospecific for each groups of substrates.

213 One serious adverse event occurred in each group (one cardiac arrest in the control group and

214 were reported for three (1%) individuals in each group (one cardiac arrest, one gastric adenocarcino

215 In each group, orthotopic kidney transplantation was perfor

216 When sample size is small (5 in each group), our proposed Bon-EV procedure has performan

217 significantly exceeding the 30% threshold in each group (P < .001, 1-sided).

218 BOP, PD and TC, PD and TG, and CAL and TG in each group (P <0.01).

219 significant difference from baseline within each group (P <0.05), with a difference in clinical and

220 ds varied whether tramadol was included (96% each group, P = 1.00) or excluded (39% vs 80%, P < 0.001

221 id-negative urine samples were equal (46% in each group, P=0.91).

222 ates were similar at 12 months (11 deaths in each group; P = .97).

223 Each group participated in three teaching scenarios, via

224 control: 4 [3.8%]), femur/hip fracture (2 in each group), pneumonia (training: 2, control: 0), urinar

225 ch spread between 'hosts' and 'vectors'-with each group possessing distinct epidemiological character

226 Each group produced a prioritised list of goals, activit

227 Each group proposed updated treatment thresholds, and al

228 (1.5x10(6) cells/kg) or placebo; at 90 days, each group received the alternative treatment.

229 Two participants, one from each group, reported persistent erythema, which was cons

230 Each group represents a distinctive pollination mode lin

231 usters contigs into different groups so that each group represents a haplotype.

232 233/219, and 2,091/1,827 cases/controls for each group, respectively).

233 Each group reviewed relevant literature and wrote drafts

234 The primary outcome was each group's median surgical supply cost per case.

235 Within each group, samples were divided into 2 subgroups ( n =

236 Within each group, seasonal shifts in community formed cool (sp

237 Half of each group slept during the delay, while the other half

238 Assignment to each group (ST-PD or AFA-PD) was randomized by blocks an

239 rticipants, the comparable size of effect in each group suggested a more general, rather than disease

240 CCA finds the linear combination in each group that maximizes the Pearson correlation.

241 Three deaths occurred in each group that were attributed to DEB-TACE.

242 could reveal microbial signatures unique to each group that will increase understanding of the role

243 tion of amino acid profiles revealed that in each group the majority of amino acids were below normal

244 Of 184 randomized participants (92 to each group), the final analysis included 88 IPLA and 87

245 Tuberculosis developed in 6 women (3 in each group); the incidence rate was 0.60 per 100 person-

246 Within each group, the absolute difference in proportional use

247 ing combinations of top reactive antigens in each group, the results reveal sensitivities of 60.0%, 7

248 ublic good spill over and benefit members in each group to different degrees.

249 e due to screening and diagnostic work-up in each group via mean lead times (MLTs), which were estima

250 or reaching >/=1000 mg of peanut protein) in each group vs placebo patch after 12 months.

251 The mean (SD) age for each group was 58.3 (10.6) years, 56.8 (10.3) years, and

252 The mean age in each group was 58.9, 54.7 and 59.3 years, respectively;

253 The TLICS score of each group was analyzed and the degree of consistent wit

254 rmined for each lesion, and then the mean of each group was calculated.

255 ) post-vaccination, upon which a subset from each group was divided and allocated to a receive a boos

256 0) postvaccination, upon which a subset from each group was divided and allocated to a receive a boos

257 Each group was divided into three subgroups based on axi

258 One participant in each group was excluded after randomisation, leaving 412

259 One patient in each group was lost to follow-up.

260 Each group was subdivided into CHC-without LC or HCC (N-

261 Within each group, we compared VDD and LVD prevalence by levels

262 g imbalances in the number of individuals in each group were adjusted using propensity score methods.

263 Interventions in each group were analyzed with chi-square tests.

264 of GFR-VIM, and the risks of incident AF by each group were compared.

265 ncreas graft survival and rejection rates of each group were compared.

266 igs reach market weight, half of the pigs in each group were culled ("market weight" groups).

267 Three dogs from each group were euthanized and tissue collected at 360 m

268 tion between tumour size and SUVmax-T within each group were evaluated statistically.

269 592 patients in each group were included in this analysis.

270 different contexts, the neural responses of each group were initially different but gradually fell i

271 After SLT, patients randomized into each group were instructed to use an unmarked drop 4 tim

272 ons between ECN/DMN and behavioral scores in each group were not significant, which was possibility d

273 zanavir group (n=249); two participants from each group were randomised to treatment but did not rece

274 for the 2013-14 influenza season and half of each group were randomly allocated to free vaccines for

275 The data assembled and analyzed by each group were reviewed by all authors and combined int

276 tive methods, and the top 181 compounds from each group were selected.

277 s (EuroQol 5 Dimensions) and angina class in each group were similar at 12 months.

278 enty-one days later half of the animals from each group were treated with either donepezil or isovolu

279 Sixty eggs - randomly selected from each group - were analysed for physicochemical propertie

280 Four of these (two in each group) were considered to be persistent disease.

281 Six patients (two from each group) were excluded.

282 derwent randomization, the first 218 (109 in each group) were included in the primary intention-to-tr

283 Overall, 120 participants (60 in each group) were included, and 239 eyes were analyzed (1

284 A total of 1,248 children (624 randomized to each group) were recruited, and 1,096 (549 in the interv

285 In total, 1,248 children (624 randomized to each group) were recruited, and 1,096 (549 intervention,

286 A total of 252 blood cultures, 126 in each group, were included in the final analysis.

287 actions were mild, transient, and similar in each group, whereas none of the spontaneously reported a

288 glycated hemoglobin level was 7.5+/-1.2% in each group, whereas the mean fasting plasma glucose leve

289 ower than that before the differentiation in each groups, which is in appropriate to the cell numbers

290 KCCA can reveal contribution of variables in each group; which enables in-depth structural analysis.

291 y endpoint was the proportion of patients in each group with an mUFC concentration of less than or eq

292 cs, 20 918 patients were analyzed (10 459 in each group with BE or self-expanding valves).

293 rimary outcome was proportion of patients in each group with delayed bleeding, defined as evident hem

294 spatially distinct independent components in each group, with generation of local circuits increasing

295 caling and root planing (SRP) and placebo in each group, with minimum 10 participants and follow-up p

296 pleted 1-year follow-up, with one patient in each group withdrawing after surgery (per-protocol popul

297 One participant from each group withdrew after consent, before intervention,

298 One patient died in each group within 30 days.

299 Animals representing the median injury in each group within each litter (n = 277, 44.5%) were also

300 Subconjunctival injection for each group (XG-102 90 mug, XG-102 900 mug, or placebo) w